141P Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan

Y-C Tsai,J-R Li,P.J Su,Y-L Su,H-J Chung,C-C Li,C-P Huang,J-C Guo,C-S Chen,E Wang,V Perrot,Y.H Chang

doi:10.1016/j.annonc.2022.10.176

141P Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan

Y-C Tsai, J-R Li + Show 10 more

https://doi.org/10.1016/j.annonc.2022.10.176

Copy DOI

Export

Save

Cite

Journal: Annals of Oncology

Publication Date: Nov 1, 2022

Affiliation: National Taiwan University Hospital, Kaohsiung Medical University

#Cell Carcinoma In Taiwan #Prior Antiangiogenic Therapy #Carcinoma In Taiwan #Cabozantinib In Patients #Advanced Renal Cell Carcinoma #Treatment Of Renal Cell Carcinoma #Real-world Patterns #Real-world Effectiveness #Treatment Of Carcinoma #Prior Therapy

Abstract
Full-Text
Similar Papers

Abstract

Listen

This study describes the real-world prescribing patterns, effectiveness, and tolerability of cabozantinib in patients in Taiwan with advanced renal cell carcinoma (aRCC) that progressed despite prior antiangiogenic therapy.

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

141P Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan